Atlas Trials

Radius Pharmaceuticals, Inc.

9 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Radius Pharmaceuticals, Inc.

RecordFirmDate
A Phase 3 Extension Study of RAD011 (Cannabidiol Oral Solution) in Patients With Prader-Willi Syndrome (NCT05387798)Radius Pharmaceuticals, Inc.2023-01-01
A Study to Assess RAD011 (Cannabidiol Oral Solution) for the Treatment of Participants With Prader-Willi Syndrome (NCT05098509)Radius Pharmaceuticals, Inc.2022-04-13
A Study to Assess the Long-Term Safety of Pharmaceutical Grade Synthetic Cannabidiol Oral Solution in Participants With Prader-Willi Syndrome (NCT03458416)Radius Pharmaceuticals, Inc.2018-09-06
Cannabidiol Oral Solution for the Treatment of Patients With Prader-Willi Syndrome (NCT02844933)Radius Pharmaceuticals, Inc.2018-05-09
Long-Term Safety of Pharmaceutical Grade Synthetic Cannabidiol Oral Solution in Pediatric Participants With Treatment-Resistant Childhood Absence Seizures (NCT03355300)Radius Pharmaceuticals, Inc.2018-02-20
Cannabidiol Oral Solution in Pediatric Participants With Treatment-Resistant Childhood Absence Seizures (NCT03336242)Radius Pharmaceuticals, Inc.2017-12-29

Track Radius Pharmaceuticals, Inc. automatically

Every clearance here is in the API, with alerts when new ones post.